Planmeca Viso G3 the Newest Member of the Company’s Family of CBCT Units

Note: This product does not yet have a release date in North America

Planmeca Viso® G3, the newest member of the company’s Planmeca Viso® family of CBCT units, is designed to offer dental practices all the imaging tools they need–with the full benefits of proven next-generation imaging technology.

The new unit—which debuted at IDS 2023 in Cologne, Germany earlier this month—is a true multifunctional CBCT device, covering all extraoral imaging needs from 2D to 3D imaging. Alongside Planmeca Viso® G7 and Planmeca Viso® G5, it completes the company’s line of cutting-edge CBCT units.

For dental practitioners, Planmeca Viso G3 brings industry-leading usability and visibility for various clinical needs, including endodontic treatments and implant planning. With a field of view (FOV) ranging from 3 x 3 to 20 x 10 cm, the unit not only offers high-quality 3D images of the entire dentition, but is able to capture detailed panoramic as well as extraoral bitewing images for interproximal diagnostics. Additionally, the unit can be equipped with the Planmeca ProCeph™ one-shot cephalostat and, when the time is right, upgraded to Planmeca Viso G5 for a larger maximum 3D volume.

The new imaging unit also comes with all the benefits of Planmeca’s tried-and-true Viso technology. This includes easy-to-use imaging programs, a live video view for successful patient positioning and virtual FOV adjustments, freely adjustable 3D volume size and anatomical target selection as well as scientifically proven Planmeca Ultra Low Dose™ imaging. For added confidence and to reduce the need for retakes, the unit also enables scout imaging for fine tuning the 3D volume before acquisition, according to the manufacturer.

In addition, Planmeca Viso G3 introduces a new user interface, which has been modelled after the modern look and feel of the Planmeca Romexis® dental software. The intuitive and adaptable user interface will be made available to existing Planmeca Viso users as well.

As with all Planmeca Viso units, Planmeca Viso G3 has been designed with the ALADA principle in mind to ensure that images are captured with the lowest possible patient doses while maintaining diagnostically acceptable image quality. For livelier patients, the unit can also be enhanced with Planmeca CALM® movement artifact correction, which can be applied either before exposure or after the scan is complete.

“Ever since the launch of the Planmeca Viso G7 full-skull imaging unit, we have witnessed a growing demand for its advanced imaging technology. With Planmeca Viso G3, we wanted to make Planmeca’s premium Viso technology available to everyone. Now, with the Planmeca Viso family complete, we have a dedicated unit for every imaging need,” states Timo Müller, vice president of Planmeca’s x-ray division.